SITraN Seminar: Monday 18 September 2017: 13:00 – 14:00: Professor Jackie Hunter, Chief Executive Officer of Benevolent Bio, London

Title:  “The importance of AI on Drug Discovery”

Speaker:  Professor Jackie Hunter, Chief Executive, Benevolent Bio, CBE PhD HonDSc FMedSci FBPharmacolS FRSB

Venue: Rooms B02/B03, SITraN, 385a Glossop Road, Sheffield, S10 2HQ

Background

Jackie Hunter is the Chief Executive Officer of Benevolent Bio. Benevolent
Bio unites traditional pharmaceutical development methodology with
Artificial Intelligence to augment the research capabilities of its drug
scientists so that they can gain new insights to increase the efficiency of
medicines development.  Jackie has over thirty years of experience in the
bioscience research sector, working across academia and industry
including leading neurology and gastrointestinal drug discovery and early
clinical development for GlaxoSmithKline.  She founded OI Pharma
Partners in 2010 to support the life science sector in harnessing the
power of open innovation and most recently was Chief Executive of the
Biotechnology and Biological Sciences Research Council.  She holds a
personal chair from St George's Hospital Medical School, which was
awarded in recognition of her contribution to bioscience research. In
2010 she was awarded a CBE in the Queen's Birthday Honours list for
Services to the Pharmaceutical Industry.